See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Liberation Day
Donald Trump
Baseball
Trade War
Natural Disasters
Senate
Social Media
Trade
Soccer
Stock Markets
Tennis
Published • loading... • Updated

Cerevance to proceed with Phase III Parkinson’s trial despite Phase II setback

Summary by Clinical Trials Arena
The pivotal, Phase III study will evaluate the change in average daily “OFF” time in Parkinson's patients dosed with Cerevance's solengepras.The post Cerevance to proceed with Phase III Parkinson’s trial despite Phase II setback appeared first on Clinical Trials Arena.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
neurologylive.comneurologylive.com

Vibrotactile Stimulation Device Shows Promise in Addressing Gait Issues in Parkinson Disease

A pilot study, presented at the 2025 AD/PD conference, evaluating the CUE1 device suggests it may help improve motor symptoms and reduce fall risk in patients with Parkinson disease.

Read Full Article
Clinical Trials ArenaClinical Trials Arena

Cerevance to proceed with Phase III Parkinson’s trial despite Phase II setback

The pivotal, Phase III study will evaluate the change in average daily “OFF” time in Parkinson's patients dosed with Cerevance's solengepras.The post Cerevance to proceed with Phase III Parkinson’s trial despite Phase II setback appeared first on Clinical Trials Arena.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Clinical Trials Arena broke the news in on Wednesday, April 2, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Parkinson

Parkinson

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal